Duke Accelerated Transcranial Magnetic Stimulation for Focal Hand Dystonia

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This study aims to investigate the impact of accelerated transcranial magnetic stimulation (TMS) on brain function and behavior in patients with focal hand dystonia. Previous research demonstrated that individualized TMS improved dystonic behavior after one session. Building on this, the current study administers four TMS sessions in a day, with assessments conducted in four weeks, twelve weeks, and 20 weeks after each session. The research involves 8 in-person and 6 virtual visits focused on functional MRI brain scans and writing behavior analysis. The potential risk of seizures from TMS is mitigated through careful screening, adhering to safety guidelines. The study's main benefit is enhancing dystonic behavior and deepening the understanding of brain changes caused by TMS in focal hand dystonia, paving the way for further advancements in clinical therapy for this condition.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• 18yrs and older

• Diagnosed with isolated focal hand by Neurologist

• Right-hand dominant

• Must be able to sign an informed consent

• Must be literate

Locations
United States
North Carolina
Duke University Health System
RECRUITING
Durham
Contact Information
Primary
Noreen Bukhari-Parlakturk, MD PhD
movdisres@dm.duke.edu
(919) 668-2879
Backup
Alaa Norain, MBS
movdisres@dm.duke.edu
(919) 668-2879
Time Frame
Start Date: 2023-12-21
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 20
Treatments
Active_comparator: TMS to primary somatosensory cortex
Participants received TMS sessions at primary somatosensory cortex
Sham_comparator: TMS at low amplitude to primary somatosensory cortex
Participants receive TMS at a cortical target at smaller amplitude
Related Therapeutic Areas
Sponsors
Collaborators: American Academy of Neurology
Leads: Duke University

This content was sourced from clinicaltrials.gov